The global COVID-19 Saliva Screening Test Potential market size is expected to be worth around US$ 3,606.2 billion by 2030, according to a new report by Vision Research Reports.
The global COVID-19 Saliva Screening Test Potential market size was valued at US$ 3055.9 billion in 2020 and is anticipated to grow at a CAGR of 6.8% during forecast period 2021 to 2030.
Report Coverage
Report Scope | Details |
Market Size | US$ 3,606.2 billion by 2030 |
Growth Rate | CAGR of 6.8% From 2021 to 2030 |
Base Year | 2021 |
Forecast Period | 2021 to 2030 |
Segments Covered | Location, Technology, Mode |
Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Companies Mentioned | ARUP Laboratories, Vatic Health, MOgene, Psomagen Inc., DxTerity Diagnostics, Inc., Ambry Genetics, Fluidigm Corporation, Phosphorus Diagnostics LLC, Gravity Diagnostics, DNA Genotek, Inc., Quidel Corporation, Abbott, LumiraDX, FluroTech Ltd. |
Growth Factors
This is primarily due to the various advantages offered by saliva-based tests, increasing product approvals by regulatory bodies, and a paradigm shift toward point-of-care testing. The fluorescence-labeled antigen/antibodies test is one of the recent saliva-based COVID-19 screening tests in the market which is based on the principles of fluorescence detection, biochemistry, robotics automation, and cloud computing, As the number of people visiting public places is increasing and reaching pre-pandemic statistics in a few countries, there is a growing demand for rapid, point-of-care COVID-19 tests to mitigate viral transmission from asymptomatic people. This has enhanced the R&D for the development of simple yet effective saliva-based tests and is expected to create lucrative opportunities for several developers.
Report Highlights
The fluorescence-labeled antigen/antibodies testing segment dominated the market for COVID-19 saliva screening test potential and accounted for the largest revenue share of 100% in 2020. Fluorescence-labeled antigen/antibodies testing LLC makes use of the CompleTest platform to diagnose an array of viral infections, including SARS-COV-2. This test can affirm the development of immunity in an individual against COVID-19. The company develops tests, which can be administered at the point of collection, with a turnaround time of 15 minutes.
The decentralized testing segment dominated the market COVID-19 saliva screening test potential and accounted for the largest revenue share of 98.2% in 2020. Increasing adoption of saliva-based COVID-19 screening tests by several developers contributes to the revenue generated by this segment. For instance, e7 Health, a laboratory located in Las Vegas, offers at-work or at-home COVID-19 tests authorized by the FDA. The tests are collected through saliva specimens.
Centralized settings can play an integral role in the saliva-based diagnosis of SARS-CoV-2 infections, as these are not rapid tests that can be performed near the patient. Ease of sample collection, minimization of collection supplies required for saliva testing, reduced tests in the testing protocol, and access to instruments are some of the reasons that can be attributed to the strong focus on saliva-based COVID-19 diagnosis across centralized settings.
North America dominated the COVID-19 saliva screening test potential market and accounted for the largest revenue share of 91.0% in 2020. The introduction of several new products by emerging start-ups and the presence of home-grown key players engaged in the development and manufacturing of diagnostic as well as screening tests based on various technologies has majorly contributed to the dominance of the region.
Key Players
ARUP Laboratories
Vatic Health
MOgene
Psomagen Inc.
DxTerity Diagnostics, Inc.
Ambry Genetics
Fluidigm Corporation
Phosphorus Diagnostics LLC
Gravity Diagnostics
DNA Genotek, Inc.
Quidel Corporation
Abbott
LumiraDX
FluroTech Ltd.
Market Segmentation
Location Outlook(North America)
Travel Stations
Airports
Cruise
Ports
Train Stations
Border Crossing
Sports Arenas
Concert Halls
Shopping Malls and Centers
Amusement Parks
Corporate Campus Environments
Universities & Colleges
Factories
Food Processing Plants
Meat Packing Plants
Pharmaceutical Plants
Mining
Retail Working Warehouses
Location Outlook (Other Region)
Travel Stations
Sports Arenas
Entertainment Venues
Corporate Campus Environments
Universities & Colleges
Factories
Technology Outlook
Fluorescence-labeled antigen/antibodies testing
RT-PCR
CRISPR-Cas9
Mode Outlook
Centralized Testing
Decentralized Testing
Regional Outlook
North America
U.S.
Canada
Europe
Asia Pacific
Rest of World
The COVID-19 Saliva Screening Test Potential market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of COVID-19 Saliva Screening Test Potential market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global COVID-19 Saliva Screening Test Potential market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the COVID-19 Saliva Screening Test Potential market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted COVID-19 Saliva Screening Test Potential market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the COVID-19 Saliva Screening Test Potential capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of COVID-19 Saliva Screening Test Potential by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global COVID-19 Saliva Screening Test Potential market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major COVID-19 Saliva Screening Test Potential market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of COVID-19 Saliva Screening Test Potential market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the COVID-19 Saliva Screening Test Potential industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
COVID-19 Saliva Screening Test Potential market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to COVID-19 Saliva Screening Test Potential market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of COVID-19 Saliva Screening Test Potential market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new COVID-19 Saliva Screening Test Potential market. These factors have benefited the growth of the global market for COVID-19 Saliva Screening Test Potential. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for COVID-19 Saliva Screening Test Potential. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of COVID-19 Saliva Screening Test Potential are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global COVID-19 Saliva Screening Test Potential Market, By Location (North America)
7.1. COVID-19 Saliva Screening Test Potential Market, by Location (North America), 2020-2030
7.1.1. Travel Stations
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Sports Arenas
7.1.2.1. Market Revenue and Forecast (2016-2030)
7.1.3. Concert Halls
7.1.3.1. Market Revenue and Forecast (2016-2030)
7.1.4. Shopping Malls and Centers
7.1.4.1. Market Revenue and Forecast (2016-2030)
7.1.5. Amusement Parks
7.1.5.1. Market Revenue and Forecast (2016-2030)
7.1.6. Corporate Campus Environments
7.1.6.1. Market Revenue and Forecast (2016-2030)
7.1.7. Universities & Colleges
7.1.7.1. Market Revenue and Forecast (2016-2030)
7.1.8. Factories
7.1.8.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global COVID-19 Saliva Screening Test Potential Market, By Location (Other Region)
8.1. COVID-19 Saliva Screening Test Potential Market, by Location (Other Region), 2020-2030
8.1.1. Travel Stations
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Sports Arenas
8.1.2.1. Market Revenue and Forecast (2016-2030)
8.1.3. Entertainment Venues
8.1.3.1. Market Revenue and Forecast (2016-2030)
8.1.4. Corporate Campus Environments
8.1.4.1. Market Revenue and Forecast (2016-2030)
8.1.5. Universities & Colleges
8.1.5.1. Market Revenue and Forecast (2016-2030)
8.1.6. Factories
8.1.6.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global COVID-19 Saliva Screening Test Potential Market, By Technology
9.1. COVID-19 Saliva Screening Test Potential Market, by End User, 2020-2030
9.1.1. Fluorescence-labeled antigen/antibodies testing
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. RT-PCR
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. CRISPR-Cas9
9.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global COVID-19 Saliva Screening Test Potential Market, By Mode
10.1. COVID-19 Saliva Screening Test Potential Market, by Mode, 2020-2030
10.1.1. Centralized Testing
10.1.1.1. Market Revenue and Forecast (2016-2030)
10.1.2. Decentralized Testing
10.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 11. Global COVID-19 Saliva Screening Test Potential Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Location (North America) (2016-2030)
11.1.2. Market Revenue and Forecast, by Location (Other Region) (2016-2030)
11.1.3. Market Revenue and Forecast, by Technology(2016-2030)
11.1.4. Market Revenue and Forecast, by Mode (2016-2030)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Location (North America) (2016-2030)
11.1.5.2. Market Revenue and Forecast, by Location (Other Region) (2016-2030)
11.1.5.3. Market Revenue and Forecast, by Technology(2016-2030)
11.1.5.4. Market Revenue and Forecast, by Mode (2016-2030)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Location (North America) (2016-2030)
11.1.6.2. Market Revenue and Forecast, by Location (Other Region) (2016-2030)
11.1.6.3. Market Revenue and Forecast, by Technology(2016-2030)
11.1.6.4. Market Revenue and Forecast, by Mode (2016-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Location (North America) (2016-2030)
11.2.2. Market Revenue and Forecast, by Location (Other Region) (2016-2030)
11.2.3. Market Revenue and Forecast, by Technology(2016-2030)
11.2.4. Market Revenue and Forecast, by Mode (2016-2030)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Location (North America) (2016-2030)
11.2.5.2. Market Revenue and Forecast, by Location (Other Region) (2016-2030)
11.2.5.3. Market Revenue and Forecast, by Technology(2016-2030)
11.2.5.4. Market Revenue and Forecast, by Mode (2016-2030)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Location (North America) (2016-2030)
11.2.6.2. Market Revenue and Forecast, by Location (Other Region) (2016-2030)
11.2.6.3. Market Revenue and Forecast, by Technology(2016-2030)
11.2.6.4. Market Revenue and Forecast, by Mode (2016-2030)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Location (North America) (2016-2030)
11.2.7.2. Market Revenue and Forecast, by Location (Other Region) (2016-2030)
11.2.7.3. Market Revenue and Forecast, by Technology(2016-2030)
11.2.7.4. Market Revenue and Forecast, by Mode (2016-2030)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Location (North America) (2016-2030)
11.2.8.2. Market Revenue and Forecast, by Location (Other Region) (2016-2030)
11.2.8.3. Market Revenue and Forecast, by Technology(2016-2030)
11.2.8.4. Market Revenue and Forecast, by Mode (2016-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Location (North America) (2016-2030)
11.3.2. Market Revenue and Forecast, by Location (Other Region) (2016-2030)
11.3.3. Market Revenue and Forecast, by Technology(2016-2030)
11.3.4. Market Revenue and Forecast, by Mode (2016-2030)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Location (North America) (2016-2030)
11.3.5.2. Market Revenue and Forecast, by Location (Other Region) (2016-2030)
11.3.5.3. Market Revenue and Forecast, by Technology(2016-2030)
11.3.5.4. Market Revenue and Forecast, by Mode (2016-2030)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Location (North America) (2016-2030)
11.3.6.2. Market Revenue and Forecast, by Location (Other Region) (2016-2030)
11.3.6.3. Market Revenue and Forecast, by Technology(2016-2030)
11.3.6.4. Market Revenue and Forecast, by Mode (2016-2030)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Location (North America) (2016-2030)
11.3.7.2. Market Revenue and Forecast, by Location (Other Region) (2016-2030)
11.3.7.3. Market Revenue and Forecast, by Technology(2016-2030)
11.3.7.4. Market Revenue and Forecast, by Mode (2016-2030)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Location (North America) (2016-2030)
11.3.8.2. Market Revenue and Forecast, by Location (Other Region) (2016-2030)
11.3.8.3. Market Revenue and Forecast, by Technology(2016-2030)
11.3.8.4. Market Revenue and Forecast, by Mode (2016-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Location (North America) (2016-2030)
11.4.2. Market Revenue and Forecast, by Location (Other Region) (2016-2030)
11.4.3. Market Revenue and Forecast, by Technology(2016-2030)
11.4.4. Market Revenue and Forecast, by Mode (2016-2030)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Location (North America) (2016-2030)
11.4.5.2. Market Revenue and Forecast, by Location (Other Region) (2016-2030)
11.4.5.3. Market Revenue and Forecast, by Technology(2016-2030)
11.4.5.4. Market Revenue and Forecast, by Mode (2016-2030)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Location (North America) (2016-2030)
11.4.6.2. Market Revenue and Forecast, by Location (Other Region) (2016-2030)
11.4.6.3. Market Revenue and Forecast, by Technology(2016-2030)
11.4.6.4. Market Revenue and Forecast, by Mode (2016-2030)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Location (North America) (2016-2030)
11.4.7.2. Market Revenue and Forecast, by Location (Other Region) (2016-2030)
11.4.7.3. Market Revenue and Forecast, by Technology(2016-2030)
11.4.7.4. Market Revenue and Forecast, by Mode (2016-2030)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Location (North America) (2016-2030)
11.4.8.2. Market Revenue and Forecast, by Location (Other Region) (2016-2030)
11.4.8.3. Market Revenue and Forecast, by Technology(2016-2030)
11.4.8.4. Market Revenue and Forecast, by Mode (2016-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Location (North America) (2016-2030)
11.5.2. Market Revenue and Forecast, by Location (Other Region) (2016-2030)
11.5.3. Market Revenue and Forecast, by Technology(2016-2030)
11.5.4. Market Revenue and Forecast, by Mode (2016-2030)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Location (North America) (2016-2030)
11.5.5.2. Market Revenue and Forecast, by Location (Other Region) (2016-2030)
11.5.5.3. Market Revenue and Forecast, by Technology(2016-2030)
11.5.5.4. Market Revenue and Forecast, by Mode (2016-2030)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Location (North America) (2016-2030)
11.5.6.2. Market Revenue and Forecast, by Location (Other Region) (2016-2030)
11.5.6.3. Market Revenue and Forecast, by Technology(2016-2030)
11.5.6.4. Market Revenue and Forecast, by Mode (2016-2030)
Chapter 12. Company Profiles
12.1. ARUP Laboratories
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Vatic Health
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. MOgene
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Psomagen Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. DxTerity Diagnostics, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Ambry Genetics
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Fluidigm Corporation
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Phosphorus Diagnostics LLC
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Gravity Diagnostics
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. DNA Genotek, Inc.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. Quidel Corporation
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives
12.12. Abbott
12.12.1. Company Overview
12.12.2. Product Offerings
12.12.3. Financial Performance
12.12.4. Recent Initiatives
12.13. LumiraDX
12.13.1. Company Overview
12.13.2. Product Offerings
12.13.3. Financial Performance
12.13.4. Recent Initiatives
12.14. FluroTech Ltd.
12.14.1. Company Overview
12.14.2. Product Offerings
12.14.3. Financial Performance
12.14.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
Glossary of Terms